IDx LLC, with assistance from Hogan Lovells, achieved a major grant of De Novo classification from the U.S. Food and Drug Administration for the novel artificial…
IDx LLC’s First medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults
